Verb Tech (NASDAQ:VERB) reported quarterly sales of $2.20 million which missed the analyst consensus estimate of $2.95 million by 25.42 percent. This is a 24.14 percent decrease over sales of $2.90 million the same
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.